Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EIF4A3 | P38919 | 1/20 | 0.31 |
| ▸ | HMGCR | P04035 | 2/20 | 0.30 |
| ▸ | RARG | P13631 | 1/20 | 0.30 |
| ▸ | RXRA | P19793 | 1/20 | 0.30 |
| ▸ | PPARG | P37231 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25063760 | 0.85 | MRGPRX4 (0.38) | — | |
| SCHEMBL25063758 | 0.84 | EIF4A3 (0.33) | EIF4A3HMGCRRARGRXRAPPARG | |
| SCHEMBL24934780 | 0.83 | FFAR4 (0.36) | EIF4A3RARGRXRAPPARG | |
| SCHEMBL24935559 | 0.82 | FFAR4 (0.35) | EIF4A3RARGRXRAPPARG | |
| SCHEMBL25063754 | 0.78 | MRGPRX4 (0.40) | — | |
| SCHEMBL24934753 | 0.76 | KDM4E (0.33) | — | |
| SCHEMBL25063891 | 0.72 | RAB9A (0.41) | RXRA | |
| SCHEMBL25063930 | 0.72 | EIF4A3 (0.38) | EIF4A3RARGRXRAPPARG | |
| SCHEMBL24934777 | 0.71 | CCNT1 (0.37) | — | |
| SCHEMBL24934759 | 0.70 | FFAR1 (0.40) | PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230054270-A1 | BIFUNCTIONAL COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF | SUZHOU KINTOR PHARMACEUTICALS, INC. (CN) | 2023-02-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230054270-A1 | BIFUNCTIONAL COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF | AR, SHBG, NR5A1 | EIF4A3 3940/4885HMGCR 700/4885RARG 1795/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.